NSEGeneral Updates2d ago · 12 Oct 2026, 06:23 pm

General Updates

Bajaj Healthcare Limited · BAJAJHCARE

✦ AI SummaryDivestiture

Bajaj Healthcare Limited has informed the Exchange about the sale of an undertaking to Spa Vet Private Limited and Indosol Pure Technologies Private Limited for Rs. 14.67 Crores. The transaction does not fall within related party transactions and the trading window for dealing in securities of the company remains closed.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bajaj Healthcare Limited has informed the Exchange about General Updates

Attachments (1)

📄

BAJAJHCARE_12102026181617_Intimation_for_Sale_of_Plot.pdf

pdf

Download →
View document text
Ref: BHL/ STEX 41/ 2026-27 Date: October 12, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza, Dalal Street Bandra Kurla Complex Bandra (East) Mumbai – 400 001 Mumbai-400051 Scrip Code: 539872 Symbol: BAJAJHCARE Dear Sir/Madam, Subject: Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that the Company has executed a Deed of Assignment with Spa Vet Private Limited and Indosol Pure Technologies Private Limited for the sale of an undertaking of the Company situated at Plot No. D-2/CH/42 & D-2/CH/43 Dahej Industrial Area, GIDC, Bharuch, Gujarat. We further confirm that none of the promoter/ promoter group/ group companies have any interest in the aforesaid buyers and the transaction does not fall within the purview of related party transactions. Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended & as per the Company’s code of Internal Procedures and Conduct for Regulating, Monitoring & Reporting of trading in securities, the Trading window for dealing in securities of the Bajaj Healthcare Limited shall continue to remain closed for all Designated Persons including their immediate relatives in terms of our earlier disclosure dated September 23, 2026. The brief details, in accordance with the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as “Annexure-I”. You are requested to take the same on record. Thanking You, For and on behalf of Bajaj Healthcare Limited Monica Tanwar Company Secretary & Compliance Officer Encl: as above BAJAJ HEALTHCARE LIMITED Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604 Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com CIN No. L99999MH1993PLC072892 Annexure-I Details required under the Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 Sr. Particulars Amount a) The amount and percentage of the turnover or revenue or The undertaking was not income and net worth contributed by such unit or division or operational during the last financial undertaking or subsidiary or associate company of the year, therefore turnover or revenue listed entity during the last financial year contribution is Nil. b) Date on which the agreement for sale has been entered into October 12, 2026 c) The expected date of completion of sale/disposal The transaction is expected to be completed upon fulfillment of conditions as mentioned under the Deed of Assignment. d) Consideration received from such sale/disposal The consideration for the transaction is Rs. 14.67 Crores (approx.). e) Brief details of buyers and whether any of the buyers belong The buyers are Spa Vet Private to the promoter/ promoter group/group companies. If yes, Limited and Indosol Pure details thereof Technologies Private Limited. Neither of the buyers belongs to the Promoter/ Promoter Group/ Group Companies of the Company. f) Whether the transaction would fall within related party No. The transaction does not fall transactions? If yes, whether the same is done at “arm’s within the purview of related party length” transactions. g) Whether the sale, lease or disposal of the undertaking is The Company obtained prior outside Scheme of Arrangement? If yes, details of the same approval of its Shareholders on including compliance with regulation 37A of LODR August 05, 2023 vide Postal Ballot Regulations. Notice dated June 28, 2023 and has complied with Regulation 37A of SEBI Listing Regulations. h) Additionally, in case of a slump sale, indicative disclosures Not Applicable provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale. BAJAJ HEALTHCARE LIMITED Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604 Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com CIN No. L99999MH1993PLC072892